SLC3A2 and mantle cell lymphoma: MCL is characterized by a near-universal presence of a t(11;14)(q13;q32) translocation bringing the CCND1 locus into close proximity with the immunoglobulin heavy-chain enhancer [4, 5], which can drive SHM in a subset of MCL cases [37].